<DOC>
	<DOCNO>NCT02866149</DOCNO>
	<brief_summary>Exploratory study blood-borne biological marker correlation clinical pathological characteristic .</brief_summary>
	<brief_title>Analysis Circulating Tumor Markers Blood ( ALCINA )</brief_title>
	<detailed_description>Exploratory multi-cohort study include different type cancer ( different organ and/or different histological type ) . Each kind blood-borne biological marker analyse corresponds cohort .</detailed_description>
	<mesh_term>Palbociclib</mesh_term>
	<criteria>1 . Patient tumoral disease ( proven suspect ) , type stage 2 . More than18 year old 3 . Signed informed consent form Additional inclusion criterion tumor sample need : 4 . Tumor consider accessible biopsy 5 . Normal blood coagulation test last blood analysis Noninclusion Criteria : 1 . Patient detention protect law 2 . Patient comply study follow geographical , social psychological reason Additional noninclusion criterion tumor sample need : 3 . Anticoagulant antiaggregant interrupt biopsy 4. centralnervous system metastasis ( unless diagnostic curative surgery plan inclusion study )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Cancer</keyword>
	<keyword>circulate tumor biomarkers</keyword>
	<keyword>circulate tumor DNA</keyword>
	<keyword>Circulating tumor Cell ( CTC )</keyword>
</DOC>